Synthesis and biological activity of new 3-chloro-4-(3-substituted phenyl)-1-(5-((2-methyl-1H-benzo[d]imidazol-1-yl) methyl)-1, 3, 4-thiadiazol-2-yl) azetidin-2-one

International Journal of ChemTech Research

Volumn 3, Issue 3, 2011, Pages 1556-1562

  Chhajed, Mahavir ^a   Shrivastav, A K ^b   Jain, Atika ^c   Kharia, Anil ^d  

^a SURESH GYAN VIHAR UNIVERSITY   (India)

^b Anand College of Pharmacy   (India)

^c Devi Ahilya College of Pharmacy   (India)

^d Modern Institute of Pharmaceutical Sciences   (India)

Author keywords

1,3,4 thiadiazoles; Antimicrobial activity; Benzimidazoles

Indexed keywords

3 CHLORO 4 (2 HYDROXYPHENYL) 1 [5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (3 SUBSTITUTED PHENYL) 1 [5 [(2METHYL 1H-BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (4 HYDROXYPHENYL) 1 [5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 (4 METHOXYPHENYL) 1 [5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2YL)AZETIDIN 2 ONE; 3 CHLORO 4 (PHENYL) 1 [5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 YL]AZETIDIN 2 ONE; 3 CHLORO 4 [4 (DIMETHYLAMINO)PHENYL] 1 [5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 HIADIAZOL 2 YL]AZETIDIN 2 ONE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CLOTRIMAZOLE; N BENZYLIDENE 5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL) 1,3,4 THIADIAZOL 2 AMINE; N SUBSTITUTED BENZYLIDENE 5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL) METHYL] 1,3,4 THIADIAZOL 2 AMINE; N(2 HYDROXYBENZYLIDENE) 5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; N(4 HYDROXYBENZYLIDENE) 5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; N(4 METHOXYBENZYLIDENE) 5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL) 1,3,4 THIADIAZOL 2 AMINE; N(SUBSTITUTED BENZYLIDENE) 5 [(2 METHYL 1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1, 3,4 THIADIAZOL 2 AMINE; N[4 (DIMETHYLAMINO)BENZYLIDENE] 5 [(2-METHYL-1H BENZO[D]IMIDAZOL 1 YL)METHYL] 1,3,4 THIADIAZOL 2 AMINE; NORFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; BACTERIAL STRAIN; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROMETRY; MASS SPECTROMETRY; NONHUMAN; PROTEUS MIRABILIS; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 79961131878     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Neu H. C., Science, 1992, 257, 1064.
2. Mullican M. D., Wilson M. W., Connor D. T., Kostlan C. R., Schrier D. J. and Dyer R. D., J Med Chem, 1993, 36,1090.
3. Dutta M. M., Goswami B. N. and Kotaky J. C. S., Chem Abstr, 1988, 108,75309q.
4. Rollas S., Oruc E. E., Kandemirli F., Shvets N. and Dimoglo S., J Med Chem, 2004, 47, 6770.
5. Hanna M. A., Girges M. M., Rasala D. and Gawinecki R., Arzeneim-Forsch/Drug Res, 1995, 45 1074.
6. Cross P. E. and Dickinson P. R., Chem Abstr, 1978, 88,190839t.
7. Zuhair M. E., Fuad A. J., Shamis E., Sabah A. K., Hanan G. and Murfied G., Chem Abstr, 1983, 98, 72006c.
8. Karegoudar P., Prasad D. J., Ashok M., Mahalinga M., Poojary B. and Holl B. S., Eur J Med Chem, 2008, 43,808.
9. Padmavathi V., Sudhakar R. G., Padmaja A., Kondaiah P. and Ali S., Eur J Med Chem, 2009, 44, 2106.
10. Lamani R. S., Shetty N. S., Kamble R. R. and Khazi I. A, Eur J Med Chem, 2009, 44, 2828.
11. Khairnar V.L., Lockhande S.R., Patel M.R. and Khadse B.G., Chem Abstr. 1981, 95, 203833h.
12. Kruse L.L., Ladd D.L., Harrsch P.B., McCabe F.L., Mong, S.M., Faucett, L. and Johnson R., J. Med. Chem. 1989, 32, 409-417.
13. Islam I., Skibo E.B., Dorr R.T. and Alberts D.S., J. Med. Chem.1991, 34, 2954-2961.
14. Habernickel V.J., Drugs made in Germany, 1992, 35, 97.
15. Fukuda T., Saito T., Tajima S., Shimohara K. and Ito K., Arzneim.-Forsch./Drug Res. 1984, 34, 805-810.
16. Nakan H., Inoue T., Kawasaki N., Miyataka H., Matsumoto H., Taguchi T., Inagaki N., Nagai H. and Satoh T., Chem. Pharm. Bull, 1999, 47, 1573-1578.
17. Can-Eke B., Puskullu M.O., Buyukbingol E. and Iscan M., Chemico-Biological Interactions, 1998, 113, 65-77.
18. Kus C., Ayhan-Klcgil G., Can-Eke B. and Iscan M. Arch. Pharm. Res, 2004, 27, 156-163.
19. Ayhan-Klcgil G., Kus C., Coban T., Can-Eke B. and Iscan M., Journal of Enzyme Inhibition and Medicinal Chemistry, 2004, 19, 129-135.
20. Goker H., Ayhan-Klcgil G., Tuncbilek M., Kus C., Ertan R., Kendi E., Ozbey S., Fort M., Garcia C. and Farre A.J., Heterocycles, 1999, 51, 2561-2573.
21. Abdel-Rahman A.E., Mahmoud A.M., El-Naggar G.M. and El-Sherief, H.A., Pharmazie 1983, 38, 589-590.
22. Soliman F.S.G., Rida S.M., Badawey E.A.M. and Kappe, T. Arch. Pharm. 1984,317, 951-958.
23. Coburn R.A., Clark M.T., Evans R.T. and Genco, R.J., J. Med. Chem. 1987, 30, 205-208.
24. Habib N.S., Abdel-Hamid S. and M. El-Hawash, Farmaco, 1989, 44, 1225-1232.
25. Goker H., Kus C., Boykin D.W., Yldz S. and Altanlar, N., Bioorg. Med. Chem. 2002, 10, 589-2596.
26. Ozden S., Karatas H., Yldz S. and Goker H., Arch. Pharm. Pharm. Med. Chem. 2004, 337, 556-562.
27. Ozden S., Atabey D., Yldz S. and Goker H., Bioorg. Med. Chem. 2005, 13, 1587-1597.
28. th edition, (Pearson Education, Singapore) 2005, 1077.
29. Ansari K. F., and Lal, C., Eur J Med Chem, 2009, 44, 2294.
30. Atlas R. M., Parks L. C. and Brown A. E., Laboratory Manual of Experimental Microbiology, (Mosby Year Book Inc, USA) 1995, 335.
31. Daniel L., Microbiology, (WCB Mc-Graw Hill, Boston), 1998, 133.
32. Microbial Type Culture Collection and Gene Bank (MTCC) Catalogue, Institute of Microbial Technology: Chandigarh, 1998, pp. 130.
33. Talesara GL, Sharma R and Nagda D P, ARKIVOC, 2006, I, 1-12.